1. Home
  2. IH vs SPRO Comparison

IH vs SPRO Comparison

Compare IH & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iHuman Inc.

IH

iHuman Inc.

HOLD

Current Price

$1.23

Market Cap

70.5M

Sector

Real Estate

ML Signal

HOLD

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

HOLD

Current Price

$1.23

Market Cap

71.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IH
SPRO
Founded
1996
2013
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.5M
71.6M
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
IH
SPRO
Price
$1.23
$1.23
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.4K
478.5K
Earning Date
03-31-2026
05-13-2026
Dividend Yield
5.88%
N/A
EPS Growth
N/A
111.81
EPS
N/A
N/A
Revenue
N/A
$66,802,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$300.00
P/E Ratio
$7.30
N/A
Revenue Growth
N/A
39.24
52 Week Low
$1.20
$1.08
52 Week High
$3.16
$3.08

Technical Indicators

Market Signals
Indicator
IH
SPRO
Relative Strength Index (RSI) 45.52 39.88
Support Level N/A $1.18
Resistance Level $1.42 $1.29
Average True Range (ATR) 0.07 0.04
MACD 0.00 0.03
Stochastic Oscillator 11.11 52.63

Price Performance

Historical Comparison
IH
SPRO

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. All of the groups revenue is generated from Chinese Mainland.

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. It is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Share on Social Networks: